ArticleJournal of personalized medicine2024

Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.

Tsutomu Anraku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.